CHATHAM, N.J., July 03, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix Pharmaceuticals or Tonix), a biopharmaceutical company, and its wholly-owned ...
The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults. The FDA has approved sumatriptan nasal spray (Tosymra) for the acute ...
Objective: To study the efficacy and practicality of treating headache in professional footballers with intranasal sumatriptan. Results: Thirty eight attacks were analysed. The two hour response ...
YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered ...
Sumatriptan is a generic prescription drug used to treat migraine and cluster headaches in adults. It’s available in three forms: a tablet that you swallow nasal (nose) spray a liquid solution that’s ...
Discover comprehensive details about Sumatriptan, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
MUMBAI, India, March 2, 2021 /CNW/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results